美國俄克拉荷馬大學2024年招聘博士后（腫瘤學）
俄克拉荷馬大學創(chuàng)建于1890年，是一所位于美國中南部俄克拉何馬州的公立研究型大學。
俄克拉荷馬大學在2021年度《美國新聞與世界報道》大學排名中位列全美第127名，世界第405位，根據(jù)CWUR世界大學排名2021年OU位列世界392名，卡內(nèi)基高等院校分類標準指定的國家最高等級研究型大學。該校石油工程專業(yè)突出，在全美排第4位，是歷史上第一個設(shè)立石油地質(zhì)專業(yè)的高等院校。擁有全球最大的建于大學內(nèi)的自然歷史博物館，其下屬OUMC為全球頂尖醫(yī)學院之一，在器官移植、神經(jīng)外科學等領(lǐng)域均處于國際領(lǐng)先地位。OU會計學以及金融學研究成果優(yōu)秀，根據(jù)楊百翰大學會計學研究排名（BYU Accounting Ranking），2021年該校累計在世界頂級會計學期刊發(fā)表論文的數(shù)量位列世界50名。學校坐落在俄克拉何馬州的諾曼，距離俄克拉荷馬城大都會區(qū)僅有30分鐘的路程。該校畢業(yè)多名杰出校友，其中包括NBA球星特雷·楊，格里芬，新浪網(wǎng)CEO曹國偉；澳門特別行政區(qū)原特首崔世安；中國科學院“百人計劃”入選者韋昌富。
NIH Funded Post-Doctoral Fellow, Associate Research Scholar
Employer
University of Oklahoma - Department of Oncology Science
Location
Oklahoma City, Oklahoma
Salary
Salary to be commensurate with experience
Closing date
Jan 2, 2025
NIH-funded post-doctoral research fellow position in pancreatic cancer metabolism
The Pankaj Singh lab at the newly established Department of Oncology Science and the NCI-designated OU Health Stephenson Cancer Center is recruiting a postdoctoral researcher to join on an NIH/NCI- funded study on pancreatic cancer metabolism. The research project involves investigating signal transduction and metabolic alterations in pancreatic cancer cells, tumor-stromal crosstalk, therapy resistance, metastasis, and immunometabolism, using cutting-edge technologies and multi-omics platforms. A successful postdoctoral candidate should have a Ph.D. in the relevant field with a strong theoretical background in basic biochemistry and molecular biology and/or human physiology. The candidate should be well versed with basic molecular biology and cell culture techniques. The project also involves utilizing cell line, organoid or mouse models of pancreatic cancer (PDX models and genetically engineered models). Some LC-MS/MS, bioinformatics, and small-animal research experience is preferred but not required. More details about our work can be found in some of our recent publications (Cancer Cell 2017 32(1):71-87; JEM 2020 217 (7):e20190745; Immunity 2019 50(3):576-590; Gastroenterology 2021 Jul 8:S0016-5085(21)03159-0; Nature Reviews Cancer 2023 Mar 27:1-20, PNAS 2024 Apr 2;121(14); Cancer Discovery 2024, 14(1):176-193; Elife 2024 Jul 8;12:RP87292; Nature Cell Biology 2024 Apr;26(4):613-627).
Our state-of-the art research program utilizes multi-omics approaches, including metabolomics, spatial metabolomics, sc-RNA-seq, epigenomics, and proteomics. Our program is well-funded by NCI, with multiple R01 grants and U54 grant on acquired therapy resistance in pancreatic cancer.
The Singh lab is a friendly and welcoming place with great excitement for cancer research. We plan to complete the recruitment process soon.
Interested candidates should submit their CV directly at Onc-Sci@ouhsc.edu.
The University of Oklahoma Health Sciences Center seeks to recruit and retain a diverse community of health professionals and scholars. We seek a community with a wide range of perspectives and experiences, and we provide equal employment opportunities to qualified applicants without regard to race, color, religion, political beliefs, national origin, age (40 or older), sex (see: Sexual Misconduct, Discrimination policy) sexual orientation, genetic information, gender identity, gender expression, disability, or veteran status.
